Open Label Extension Study of PREOS
NCT00172133
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1683
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
ALX1-11 (drug)
Sponsor
Shire